Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ilaria Caliari is active.

Publication


Featured researches published by Ilaria Caliari.


Molecular and Cellular Endocrinology | 2000

PREMATURE OVARIAN FAILURE

Walter Vegetti; Anna Marozzi; Emanuela Manfredini; Giovanna Testa; Federica Alagna; Annaelisa Nicolosi; Ilaria Caliari; Monica Taborelli; Maria Grazia Tibiletti; Leda Dalprà; Pier Giorgio Crosignani

Secondary amenorrhoea with elevated gonadotrophins occurring under the age of 40 (premature ovarian failure (POF)), and at the age between 41 and 44 years (early menopause (EM)), respectively, affects 1-2% and 5% of women in the general population. Objective of this study was to evaluate the prevalence of familial cases of POF and EM and to assess the clinical and genetic characteristics of these patients. One hundred and sixty women with idiopathic secondary amenorrhoea before the age of 45 and serum follicle-stimulating hormone (FSH) levels greater than or equal to 40 IU/l were included in the study. Tests performed on patients included complete medical history, pedigrees analysis, clinical pelvic examination, gonadotrophins and thyroid assessment, chromosomal analysis. The 160 patients included in the study showed idiopathic POF (n=130) or EM (n=30). Following pedigree assessment, we were able to identify an incidence of familial cases of 28.5% in the POF group (n=37) and of 50% in the EM group (n=15). POF and EM condition were often present in the same family. There were no differences between POF and EM patients and between familial and sporadic cases regarding age at menarche, personal history, gynaecological history, weight, height and diet habits. There was a statistically significant difference between sporadic and familial cases in age at POF onset: 32.0+/-7.3 years (12-40) compared to 35. 0+/-5.8 (18-40), respectively (P<0.05). The POF and EM families identified showed two or more affected females and transmission through either maternal or paternal relatives; in four families both maternal and paternal transmission was observed. This study suggests that idiopathic POF and EM conditions, differing only in age of menopause onset, may represent a variable expression of the same genetic disease. The different age of menopause onset in these patients may be explained by genetic heterogeneity and/or by different environmental factors. Our results indicate a high rate of familial transmission of the condition. Pedigrees analysis suggests an autosomal or an X-linked dominant sex-limited pattern of inheritance for POF and EM.


Gynecologic and Obstetric Investigation | 2001

Case-Control Study on Risk Factors for Premature Ovarian Failure

Giovanna Testa; Francesca Chiaffarino; Walter Vegetti; Annaelisa Nicolosi; Ilaria Caliari; Federica Alagna; Pier Francesco Bolis; Fabio Parazzini; Pier Giorgio Crosignani

Objective of this case-control study was to investigate the potential risk factors for premature ovarian failure (POF). Seventy-three patients with secondary hypergonadotropic amenorrhea and, as control group, 144 women with acute, non-gynecological, non-neoplastic, non-hormone-related diseases were included in the study. Information was obtained on sociodemographic characteristics, gynecological and obstetric data, general lifestile habits, smoking habits and history of selected gynecological and other clinical conditions. A statistically significant association between high education level and POF was found (p = 0.03). Parity was related to a reduced risk of POF and this reduction increased with the number of live births (p = 0.02). No association emerged between POF risk and age at menarche, cycle length and oral contraceptive use. Women with POF could not be distinguished from control women by behavioral and reproductive history, except for lower fertility. The minor influence that reproductive and lifestyle factors have on the occurrence of POF suggests that genetic inheritance plays a more important role.


Gynecologic and Obstetric Investigation | 2001

FIGO Committee for the Ethical Aspects of Human Reproduction and Women’s Health: Ethical Guidelines in the Prevention of Iatrogenic Multiple Pregnancy

N. Vitoratos; E. Salamalekis; D. Kassanos; C. Loghis; N. Panayotopoulos; E. Kouskouni; Tsutomu Takeuchi; Yoshio Yoneyama; Shunji Suzuki; Rintaro Sawa; Yasuo Otsubo; Tsutomu Araki; Francesco Bianchi-Demicheli; Frank Lüdicke; Fosco Spinedi; Attila L. Major; Regina Kulier; Aldo Campana; Thomas Gyr; David M. Sherer; P. Dar; Edmund F. Funai; Emily J. Rosenbush; Men-Jean Lee; Giuseppe Del Priore; Guttorm Haugen; Halvor Rognerud; Ysabel Casart; Teresa Proverbio; Reinaldo Marín

Accessible online at: www.karger.com/journals/goi The FIGO Committee for the Ethical Aspects of Human Reproduction and Women’s Health considers the ethical aspects of issues that impact the discipline of obstetrics, gynaecology and women’s health. The following documents represent the result of that carefully researched and considered discussion. This material is not intended to reflect an official position of FIGO but to provide material for consideration and debate about these ethical aspects of our discipline for member organizations and their constituent membership.


Human Reproduction | 2005

Health-related quality of life and need for IVF in 1000 Italian infertile couples

Guido Ragni; Paola Mosconi; Maria Pia Baldini; Edgardo Somigliana; Walter Vegetti; Ilaria Caliari; Anna Elisa Nicolosi


Fertility and Sterility | 2013

Oocyte in vitro maturation in normo-ovulatory women

Rubens Fadini; Mario Mignini Renzini; Mariabeatrice Dal Canto; Amalia Epis; Marilena Crippa; Ilaria Caliari; Claudio Brigante; Giovanni Coticchio


Fertility and Sterility | 2006

Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years’ experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists

Guido Ragni; Ilaria Caliari; Anna Elisa Nicolosi; Mariangela Arnoldi; Edgardo Somigliana; Pier Giorgio Crosignani


Fertility and Sterility | 2008

Genetic screening in 2,710 infertile candidate couples for assisted reproductive techniques: results of application of Italian guidelines for the appropriate use of genetic tests

Alessandra Riccaboni; Faustina Lalatta; Ilaria Caliari; Silvia Bonetti; Edgardo Somigliana; Guido Ragni


Fertility and Sterility | 2001

Prevalence of functional ovarian cysts in natural and stimulated cycles.

Pier Giorgio Crosignani; Federica Alagna; Annaelisa Nicolosi; Ilaria Caliari; Graziella Calanna; Guido Ragni


Fertility and Sterility | 2013

IVM rescue in high responders patients at risk of OHSS

Claudio Brigante; M. Mignini Renzini; M. Dal Canto; G. Coticchio; Ilaria Caliari; R. Fadini


Journal of Assisted Reproduction and Genetics | 2017

Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve

Mario Mignini Renzini; Claudio Brigante; Giovanni Coticchio; Mariabeatrice Dal Canto; Ilaria Caliari; Ruggero Comi; Elena De Ponti; Rubens Fadini

Collaboration


Dive into the Ilaria Caliari's collaboration.

Top Co-Authors

Avatar

Guido Ragni

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar

Pier Giorgio Crosignani

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Claudio Brigante

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge